Bristol-Myers Squibb: A Better Earnings Outlook, Stronger Momentum Heading Into 2025

JHVEPhoto/iStock Editorial via Getty Images Bristol-Myers Squibb Company (NYSE:BMY) produced its best bottom-line beat in more than five years back in July. Shares rose significantly after reporting, helping the broader Health Care Select Sector SPDR ETF (XLV) sector begin a period of outperformance against the S&P 500 ETF (SPY). It’s almost always a favorable setup when we see a gangbuster company earnings update, just as sector relative strength turns for the better.  Not surprisingly, BMY shares are  ...